RMI and FAF helpful in characterizing retinal dystrophies

Article

Using retro-mode imaging (RMI) and fundus autofluorescence (FAF) can be helpful in characterizing retinal dystrophies.

Using retro-mode imaging (RMI) and fundus autofluorescence (FAF) can be helpful in characterizing retinal dystrophies, according to a paper featured in the journal Bio Med. Central Ophthalmology.

A team led by Dr Battaglia Parodi Maurizio, Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy, included 18 consecutive patients with retinal dystrophies.

Each participant underwent ophthalmological assessments including best corrected visual acuity with ETDRS charts, blue-light fundus autofluorescence, (BL-FAF), near-infrared fundus autofluorescence (NIR-FAF) and RMI. The primary outcome was abnormal patterns on RMI and the secondary outcome was the correlation between BL-FAF findings and NIR-FAF findings.

The results revealed that the main feature of RMI is represented by a pseudo-3D pattern of all the posterior pole lesions. There were no fixed correlations between RMI, BL-AF and NIR-AF imaging. The non-invasive diagnostic tools could obtain additional information on clinical setting and patients monitoring.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.